8 Khattak A, Weber JS, Meniawy T, et al. Distant metastasis- free survival results from the randomized, phase 2 mRNA- 4157- P201/ KEYNOTE- 942 trial. JCO 2023;41:LBA9503. 16 Mørk SK, et al. J Immunother Cancer 2024;12:e008817. doi:10.1136/jitc-2024-008817Open access 9 Mørk SK, Kadivar M, Bol KF , et al. Personalized therapy with peptide- based Neoantigen vaccine (EVX- 01) including a novel adjuvant, CAF®09B, in patients with metastatic Melanoma. Oncoimmunology 2022;11:2023255. 10 Ott PA, Hu Z, Keskin DB, et al. An Immunogenic personal Neoantigen vaccine for patients with Melanoma. Nature 2017;547:217–21. 11 Awad MM, Govindan R, Balogh KN, et al. Personalized Neoantigen vaccine NEO- PV- 01 with chemotherapy and anti- PD- 1 as first- line treatment for non- squamous non- small cell lung cancer. Cancer Cell 2022;40:1010–26.